Current Edition

Improving Development of Antiepileptic Drugs for Rare Forms of Epilepsy

Jayne Abraham, PhD, Director of Medical and Scientific Affairs for Neuroscience at Worldwide Clinical Trials Therapeutic and Idil Çavuş, MD PhD is a Senior Medical Director of Medical and Scientific Affairs for Neuroscience at Worldwide Clinical Trials explain how rare diseases cover a broad range of diseases and patients, with about 50% of those affected being children. Many have a genetic component, while others arise from exposure to infections or toxins, from faulty immune responses, or occasionally from trauma or injury (e.g. traumatic brain injury (TBI)).
https://www.jforcs.com/7/wp-content/uploads/2016/07/Improving-Development.pdf